Validating Predictive Models and Biomarkers of Radiotherapy Toxicity to Reduce Side-Effects and Improve Quality of Life in Cancer Survivors

The purpose of this international study is to try to predict which patients are more likely to have side effects from radiotherapy


First Patients included in Gent (Belgium) and Manchester (UK)!

The Ghent University Hospital has recruited the first patient in June 17 and the University of Manchester has recently started patient enrolment.

First Patients included in Spain

The Vall d'Hebron hospital of Barcelona (Spain) enrolled its first patient on June 4th and the Fundación Pública Galega de Medicina Xenómica (FPGMX) in Santiago (Spain) enrolled its first patient on May 20th.

An overview of patient recruitment (31 May 2014): 17 patients in the Mount Sinai Hospital, New York (USA), 20 patients in The National Cancer Institute of Milan (Italy) and 10 patients in the University Hospitals of Leicester (UK).

The questionnaires have been tested


General Assembly Meeting 2

Second meeting of the REQUITE project will take place on 14-15  October at Deutsches Krebsforschungszentrum in Heidelberg, Germany

Tuesday, 14 October, 2014 to Wednesday, 15 October, 2014

General Assembly Meeting 3

The third meeting of the REQUITE project will take place in June 2015 in Montpellier, France